the effect of alcohol on fatty liver disease.
Not Applicable
- Conditions
- fatty liver disease
- Registration Number
- JPRN-UMIN000028735
- Lead Sponsor
- Kyoto Prefectural University of Medeicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients positive for hepatitis B surface antigen and hepatitis C virus antibody, (2) patients under treatment for thyroid disease or hormone therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link alcohol consumption to non-alcoholic fatty liver disease progression?
How does alcohol intake affect hepatic lipid metabolism in patients with non-alcoholic steatohepatitis?
What are the key biomarkers for predicting alcohol-related liver injury in fatty liver disease populations?
What comparative effectiveness data exists for lifestyle interventions versus alcohol cessation in managing fatty liver disease?
What are the potential adverse events associated with alcohol consumption in patients with alcoholic liver disease?